Damjan Glavac

Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine;University of Ljubljana, Slovenia


Damjan Glavac received his Ph.D. degree from the Faculty of Natural Sciences and Technology at the University of Ljubljana, Slovenia. In 1991, he joined Dr. Michael Dean’s group at the Laboratory of Genomic Diversity-National Cancer Institute in in Frederick, USA, as a Postdoctoral Fellow, where he was involved in the development of mutation detection techniques. He also participated in the molecular cloning of the von Hippel Lindau gene (Latif et al., 1993) and genetic analysis of the cystic fibrosis gene and several other ATP-binding cassette (ABC) transporters important in human disease and drug resistance. Currently, he is Head of the Department of Molecular Genetics at Faculty of Medicine, University of Ljubljana, and Professor of Human Genetics. His research interests include genetic analysis of disease genes involved in hereditary diseases and cancer. Dr. Glavac has authored over 130 peer-reviewed scientific publications, 3 invited articles, 2 invited editorials, 8 book chapters, more than 50 contributions to international meetings, and more than 30 invited talks. He is also active in the transfer of knowledge and novel technologies into everyday clinical practice. This resulted in refined risk prediction, targeted screening, prevention, and treatment to be developed in several hereditary diseases (e.g., multiple endocrine neoplasia type 2, Lynch syndrome, and Alport syndrome). He is a Founder and President of the Slovenian Society of Human Genetics (since 2005) and Founding Member of the Human Genome Variation Society (since 2001).

Biography Updated on 13 March 2017

Scholarly Contributions [Data Provided by ]